|
1
|
Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007.
|
Blood
|
2011
|
3.30
|
|
2
|
Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32.
|
Nat Genet
|
2010
|
2.37
|
|
3
|
Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980-2007.
|
JAMA
|
2011
|
2.31
|
|
4
|
InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions.
|
Blood
|
2010
|
2.21
|
|
5
|
Consumption of aspartame-containing beverages and incidence of hematopoietic and brain malignancies.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
2.15
|
|
6
|
Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium.
|
Int J Cancer
|
2008
|
2.01
|
|
7
|
Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies.
|
Int J Cancer
|
2009
|
2.01
|
|
8
|
Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium.
|
Clin Gastroenterol Hepatol
|
2008
|
1.91
|
|
9
|
Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.
|
Nat Genet
|
2013
|
1.85
|
|
10
|
Differences in incidence and trends of haematological malignancies in Japan and the United States.
|
Br J Haematol
|
2013
|
1.70
|
|
11
|
Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival.
|
Blood
|
2007
|
1.63
|
|
12
|
GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma.
|
PLoS Genet
|
2011
|
1.58
|
|
13
|
Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology.
|
Blood
|
2010
|
1.56
|
|
14
|
Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk.
|
PLoS One
|
2009
|
1.52
|
|
15
|
Changes in cancer registry coding for lymphoma subtypes: reliability over time and relevance for surveillance and study.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
1.51
|
|
16
|
The epidemic of non-Hodgkin lymphoma in the United States: disentangling the effect of HIV, 1992-2009.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
1.27
|
|
17
|
Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era.
|
Blood
|
2008
|
1.26
|
|
18
|
A prospective investigation of serum 25-hydroxyvitamin D and risk of lymphoid cancers.
|
Int J Cancer
|
2009
|
1.26
|
|
19
|
Autoimmune disease and subsequent risk of developing alimentary tract cancers among 4.5 million US male veterans.
|
Cancer
|
2010
|
1.25
|
|
20
|
Personal use of hair dye and the risk of certain subtypes of non-Hodgkin lymphoma.
|
Am J Epidemiol
|
2008
|
1.23
|
|
21
|
Associations between anthropometry, cigarette smoking, alcohol consumption, and non-Hodgkin lymphoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
|
Am J Epidemiol
|
2010
|
1.21
|
|
22
|
Alcohol, smoking, and body size in relation to incident Hodgkin's and non-Hodgkin's lymphoma risk.
|
Am J Epidemiol
|
2007
|
1.21
|
|
23
|
Census and geographic differences between respondents and nonrespondents in a case-control study of non-Hodgkin lymphoma.
|
Am J Epidemiol
|
2007
|
1.20
|
|
24
|
Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors.
|
Cancer Res
|
2007
|
1.17
|
|
25
|
Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States.
|
Am J Hematol
|
2011
|
1.16
|
|
26
|
Spatial-temporal analysis of non-Hodgkin lymphoma in the NCI-SEER NHL case-control study.
|
Environ Health
|
2011
|
1.14
|
|
27
|
Smoking, alcohol use, obesity, and overall survival from non-Hodgkin lymphoma: a population-based study.
|
Cancer
|
2010
|
1.12
|
|
28
|
A case-control study of occupational exposure to trichloroethylene and non-Hodgkin lymphoma.
|
Environ Health Perspect
|
2011
|
1.10
|
|
29
|
A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma.
|
Carcinogenesis
|
2008
|
1.08
|
|
30
|
Risk of non-Hodgkin lymphoma subtypes in HIV-infected people during the HAART era: a population-based study.
|
AIDS
|
2014
|
1.05
|
|
31
|
Leveraging epidemiology and clinical studies of cancer outcomes: recommendations and opportunities for translational research.
|
J Natl Cancer Inst
|
2012
|
1.04
|
|
32
|
Menstrual and reproductive factors and risk of non-Hodgkin's lymphoma among Connecticut women.
|
Am J Epidemiol
|
2004
|
1.04
|
|
33
|
Increased risk for lymphoid and myeloid neoplasms in elderly solid-organ transplant recipients.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
1.03
|
|
34
|
Genetic variation in caspase genes and risk of non-Hodgkin lymphoma: a pooled analysis of 3 population-based case-control studies.
|
Blood
|
2009
|
1.01
|
|
35
|
Blood transfusion and risk of non-Hodgkin's lymphoma in Connecticut women.
|
Am J Epidemiol
|
2004
|
0.98
|
|
36
|
Genetic variation in Th1/Th2 pathway genes and risk of non-Hodgkin lymphoma: a pooled analysis of three population-based case-control studies.
|
Br J Haematol
|
2011
|
0.98
|
|
37
|
Converting epidemiologic studies of cancer etiology to survivorship studies: approaches and challenges.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
0.96
|
|
38
|
Incidence of lymphoid neoplasms by subtype among six Asian ethnic groups in the United States, 1996-2004.
|
Cancer Causes Control
|
2008
|
0.96
|
|
39
|
Genetic variation in cell cycle and apoptosis related genes and multiple myeloma risk.
|
Leuk Res
|
2009
|
0.94
|
|
40
|
A pooled analysis of three studies evaluating genetic variation in innate immunity genes and non-Hodgkin lymphoma risk.
|
Br J Haematol
|
2011
|
0.93
|
|
41
|
Dietary flavonoid intake and non-Hodgkin lymphoma risk.
|
Am J Clin Nutr
|
2008
|
0.93
|
|
42
|
Organochlorine exposure, immune gene variation, and risk of non-Hodgkin lymphoma.
|
Blood
|
2008
|
0.92
|
|
43
|
Plasma cell neoplasms in US solid organ transplant recipients.
|
Am J Transplant
|
2013
|
0.92
|
|
44
|
Radiation dose and subsequent risk for stomach cancer in long-term survivors of cervical cancer.
|
Int J Radiat Oncol Biol Phys
|
2013
|
0.91
|
|
45
|
Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci.
|
Am J Epidemiol
|
2015
|
0.91
|
|
46
|
Blood transfusion, anesthesia, surgery and risk of non-Hodgkin lymphoma in a population-based case-control study.
|
Int J Cancer
|
2008
|
0.90
|
|
47
|
Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma in a pooled analysis of three studies.
|
Br J Haematol
|
2010
|
0.89
|
|
48
|
Hair dye use and risk of bladder cancer in the New England bladder cancer study.
|
Int J Cancer
|
2011
|
0.88
|
|
49
|
Variations in chromosomes 9 and 6p21.3 with risk of non-Hodgkin lymphoma.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
0.88
|
|
50
|
Hodgkin lymphoma among US solid organ transplant recipients.
|
Transplantation
|
2010
|
0.88
|
|
51
|
Incidence of marginal zone lymphoma in the United States, 2001-2009 with a focus on primary anatomic site.
|
Br J Haematol
|
2014
|
0.87
|
|
52
|
Risk factors for non-Hodgkin lymphoma subtypes defined by histology and t(14;18) in a population-based case-control study.
|
Int J Cancer
|
2010
|
0.87
|
|
53
|
Burkitt lymphoma risk in U.S. solid organ transplant recipients.
|
Am J Hematol
|
2013
|
0.86
|
|
54
|
Prevalence of HIV Infection among U.S. Hodgkin lymphoma cases.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
0.86
|
|
55
|
Smoking, variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma: a pooled analysis within the InterLymph consortium.
|
Cancer Causes Control
|
2012
|
0.85
|
|
56
|
Genetic variation in N-acetyltransferases 1 and 2, cigarette smoking, and risk of non-Hodgkin lymphoma.
|
Cancer Causes Control
|
2009
|
0.85
|
|
57
|
Meat intake is not associated with risk of non-Hodgkin lymphoma in a large prospective cohort of U.S. men and women.
|
J Nutr
|
2012
|
0.85
|
|
58
|
Genetic variation in catechol-O-methyltransferase (COMT) and obesity in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial.
|
Hum Genet
|
2007
|
0.82
|
|
59
|
Prediction of the location and size of the stomach using patient characteristics for retrospective radiation dose estimation following radiotherapy.
|
Phys Med Biol
|
2013
|
0.82
|
|
60
|
Risk of non-Hodgkin lymphoma after radiotherapy for solid cancers.
|
Leuk Lymphoma
|
2012
|
0.82
|
|
61
|
Radiation dose to the esophagus from breast cancer radiation therapy, 1943-1996: an international population-based study of 414 patients.
|
Int J Radiat Oncol Biol Phys
|
2013
|
0.80
|
|
62
|
Risk of diffuse large B-cell lymphoma after solid organ transplantation in the United States.
|
Am J Hematol
|
2014
|
0.80
|
|
63
|
SLC6A3 and body mass index in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
|
BMC Med Genet
|
2009
|
0.80
|
|
64
|
Variation in effects of non-Hodgkin lymphoma risk factors according to the human leukocyte antigen (HLA)-DRB1*01:01 allele and ancestral haplotype 8.1.
|
PLoS One
|
2011
|
0.80
|
|
65
|
Lifestyle and dietary factors in relation to risk of chronic myeloid leukemia in the NIH-AARP Diet and Health Study.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
0.79
|
|
66
|
Immunostaining to identify molecular subtypes of diffuse large B-cell lymphoma in a population-based epidemiologic study in the pre-rituximab era.
|
Int J Mol Epidemiol Genet
|
2011
|
0.79
|
|
67
|
A step toward slaying the hydra of second cancers.
|
Nat Med
|
2011
|
0.79
|
|
68
|
Human leukocyte antigen class I and II alleles and overall survival in diffuse large B-cell lymphoma and follicular lymphoma.
|
ScientificWorldJournal
|
2011
|
0.78
|
|
69
|
LIM domain only 2 protein expression, LMO2 germline genetic variation, and overall survival in diffuse large B-cell lymphoma in the pre-rituximab era.
|
Leuk Lymphoma
|
2012
|
0.77
|
|
70
|
Inherited genetic variation and overall survival following follicular lymphoma.
|
Am J Hematol
|
2012
|
0.77
|
|
71
|
Re: Hair dye use, genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma, author response.
|
Carcinogenesis
|
2008
|
0.77
|
|
72
|
HLA and Risk of Diffuse Large B cell Lymphoma After Solid Organ Transplantation.
|
Transplantation
|
2016
|
0.75
|
|
73
|
Sex- and subtype-specific analysis of H2AFX polymorphisms in non-Hodgkin lymphoma.
|
PLoS One
|
2013
|
0.75
|
|
74
|
Household endotoxin levels and the risk of non-Hodgkin lymphoma.
|
Cancer Causes Control
|
2013
|
0.75
|